Gerhard Müller

Gerhard Müller

Gründer bei Gotham Therapeutics Corp.

Health Technology

Ursprung des Netzwerks ersten Grades von Gerhard Müller

EinheitArt der EinheitIndustrie
7
Subsidiary Pharmaceuticals: Major 7

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Gerhard Müller

UnternehmenSektorVerknüpfte PersonenHauptposition
CELGENE Biotechnology

Jorge DiMartino

Corporate Officer/Principal

Medical Specialties

Carlo Incerti

Chief Tech/Sci/R&D Officer

MOLMED S.P.A. Pharmaceuticals: Major

Carlo Incerti

Chairman

Miscellaneous Commercial Services

Carlo Rizzuto

Director/Board Member

University of Virginia College/University

Carlo Rizzuto

Undergraduate Degree

Miscellaneous Commercial Services

Carlo Rizzuto

Corporate Officer/Principal

Investment Managers

Jill Carroll

Private Equity Investor

College/University

Carlo Rizzuto

Doctorate Degree

University of California San Diego College/University

Jorge DiMartino

Doctorate Degree

Investment Managers

Carlo Rizzuto

Private Equity Investor

APPLIED GENETIC TECHNOLOGIES CORPORATION Pharmaceuticals: Generic

Jill Carroll

Director/Board Member

Pharmaceuticals: Major

Carlo Rizzuto

Corporate Officer/Principal

Investment Managers

Carlo Rizzuto

Consultant / Advisor

Investment Managers

Carlo Incerti

Private Equity Investor

Miscellaneous Commercial Services

Carlo Rizzuto

Corporate Officer/Principal

Pharmaceuticals: Major

Carlo Incerti

Chief Tech/Sci/R&D Officer

Medical Specialties

Carlo Incerti

Chairman

The European Association for Bioindustries

Carlo Incerti

Chairman

Università degli Studi di Modena e Reggio Emilia College/University

Carlo Incerti

Doctorate Degree

Biotechnology

Jill Carroll

Director/Board Member

Miscellaneous Commercial Services

Jill Carroll

Director/Board Member

Miscellaneous Commercial Services

Jill Carroll

Director/Board Member

Miscellaneous Commercial Services

Carlo Incerti

Director/Board Member

Medical/Nursing Services

Carlo Rizzuto

Corporate Officer/Principal

Biotechnology

Carlo Rizzuto

Chief Executive Officer

Pharmaceuticals: Major

Carlo Rizzuto

Chief Executive Officer

ARCELLX, INC. Biotechnology

Jill Carroll

Director/Board Member

International Rare Diseases Research Consortium

Carlo Incerti

Corporate Officer/Principal

Cornell University Graduate School College/University

Jorge DiMartino

Doctorate Degree

Miscellaneous Commercial Services

Jill Carroll

Carlo Rizzuto

Director/Board Member

Director/Board Member

NKARTA, INC. Biotechnology

Jill Carroll

Director/Board Member

Biotechnology

Carlo Rizzuto

Director/Board Member

KRONOS BIO, INC. Pharmaceuticals: Major

Jorge DiMartino

Chief Tech/Sci/R&D Officer

Biotechnology

Jill Carroll

Director/Board Member

Pharmaceuticals: Major

Carlo Incerti

Chairman

Pharmaceuticals: Major

Carlo Incerti

Chairman

DYNE THERAPEUTICS, INC. Biotechnology

Carlo Incerti

Director/Board Member

CENTURY THERAPEUTICS, INC. Biotechnology

Carlo Rizzuto

Director/Board Member

Biotechnology

Carlo Rizzuto

Director/Board Member

PANDION THERAPEUTICS, INC. Biotechnology

Jill Carroll

Carlo Rizzuto

Director/Board Member

Director/Board Member

Investment Managers

Jill Carroll

Corporate Officer/Principal

Packaged Software

Jill Carroll

Director/Board Member

Miscellaneous Commercial Services

Carlo Incerti

Chairman

Miscellaneous Commercial Services

Carlo Rizzuto

Director/Board Member

FirstLight Bio, Inc.

Carlo Rizzuto

President

Miscellaneous Commercial Services

Carlo Rizzuto

Director/Board Member

Statistik

International

Vereinigte Staaten 38
Italien 4
Niederlande 4
Schweiz 3
Deutschland 2

Sektoral

Health Technology 25
Commercial Services 11
Finance 7
Consumer Services 6
Health Services 2

Operativ

Director/Board Member 56
Corporate Officer/Principal 21
Independent Dir/Board Member 10
Chairman 9
Doctorate Degree 7
  1. Börse
  2. Insiders
  3. Gerhard Müller
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT